Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm
Human Pathology, 08/10/09
Tang G et al. – The authors report a patient who presented with fatigue, weight loss, leukocytosis, persistent prominent basophilia, and mild eosinophilia. The bone marrow showed features characteristic of a myeloproliferative neoplasm with a marked increase in maturing basophils. The basophils exhibited nuclear hypersegmentation, abnormal granulation, and abnormally low CD38 expression.
Related Articles
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms
British Journal of Haematology, 11/11/09
Relevance Score: 67%%
AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms
Blood, 11/09/09
Relevance Score: 67%%
Co-treatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplasm cells
Blood, 11/02/09
Relevance Score: 66%%
Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity
Clinical Cancer Research, 11/09/09
Relevance Score: 65%%
Chronic idiopathic myelofibrosis with myeloid metaplasia presenting as refractory ascites
Pediatric Blood & Cancer, 10/19/09
Relevance Score: 65%%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
A Prospective Study of Telomere Length Measured by Monochrome Multiplex Quantitative PCR and Risk of Non-Hodgkin Lymphoma
Clinical Cancer Research, 12/01/09
Results of a phase II study of bortezomib in patients with relapsed or refractory indolent lymphoma
Blood, 11/30/09
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)
British Journal of Haematology, 11/30/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Clinical Cancer Research, 12/01/09
Targeting EXT-1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
Blood, 11/30/09
Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma
Blood, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


